Liaoning Minkang Pharmaceutical

Liaoning Minkang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company established in 2007 and based in Dalian, Liaoning Province. The company operates as a joint venture, with Yantai Haizheng Pharmaceutical holding a 51% majority stake and Sichuan Kelun Pharmaceutical holding 49%. Liaoning Minkang Pharmaceutical specializes in the research, development, production, and sale of large-volume injections (LVP) in various packaging formats, including polypropylene bottles, upright polypropylene bags (Keli bags), and co-extruded bags. Its core product portfolio includes essential intravenous fluids and anti-infective injections, such as Tinidazole, Ornidazole, Glucose, Sodium Chloride, and Glucose Sodium Chloride injections, all of which are included in China's National Essential Drugs List. The company's manufacturing facility covers over 30,000 square meters and has an annual production capacity of approximately 160 million bottles/bags.